These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34251413)

  • 1. RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.
    Ntoufa S; Gerousi M; Laidou S; Psomopoulos F; Tsiolas G; Moysiadis T; Papakonstantinou N; Mansouri L; Anagnostopoulos A; Stavrogianni N; Pospisilova S; Plevova K; Makris AM; Rosenquist R; Stamatopoulos K
    Blood Adv; 2021 Jul; 5(13):2788-2792. PubMed ID: 34251413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
    Ljungström V; Cortese D; Young E; Pandzic T; Mansouri L; Plevova K; Ntoufa S; Baliakas P; Clifford R; Sutton LA; Blakemore SJ; Stavroyianni N; Agathangelidis A; Rossi D; Höglund M; Kotaskova J; Juliusson G; Belessi C; Chiorazzi N; Panagiotidis P; Langerak AW; Smedby KE; Oscier D; Gaidano G; Schuh A; Davi F; Pott C; Strefford JC; Trentin L; Pospisilova S; Ghia P; Stamatopoulos K; Sjöblom T; Rosenquist R
    Blood; 2016 Feb; 127(8):1007-16. PubMed ID: 26675346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia.
    Bretones G; Álvarez MG; Arango JR; Rodríguez D; Nadeu F; Prado MA; Valdés-Mas R; Puente DA; Paulo JA; Delgado J; Villamor N; López-Guillermo A; Finley DJ; Gygi SP; Campo E; Quesada V; López-Otín C
    Blood; 2018 Nov; 132(22):2375-2388. PubMed ID: 30181176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not so lost in translation:
    Ljungström V; Rosenquist R
    Blood; 2018 Nov; 132(22):2317-2319. PubMed ID: 30498067
    [No Abstract]   [Full Text] [Related]  

  • 5. Eukaryotic protein uS19: a component of the decoding site of ribosomes and a player in human diseases.
    Graifer D; Karpova G
    Biochem J; 2021 Mar; 478(5):997-1008. PubMed ID: 33661277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.
    Dürig J; Nückel H; Hüttmann A; Kruse E; Hölter T; Halfmeyer K; Führer A; Rudolph R; Kalhori N; Nusch A; Deaglio S; Malavasi F; Möröy T; Klein-Hitpass L; Dührsen U
    Blood; 2003 Apr; 101(7):2748-55. PubMed ID: 12456497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
    Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
    Pérez Carretero C; González T; Quijada Álamo M; Rigolin GM; Dubuc A; Villaverde Ramiro Á; Rodríguez-Sánchez A; Rubio A; Dávila J; Vidal MJ; González Gascón Y Marín I; Hernández-Rivas JÁ; Benito R; Volpe V; Davids MS; Abramson JS; Cuneo A; Dal Cin P; Rodríguez-Vicente AE; Hernández-Rivas JM
    Am J Hematol; 2024 Sep; 99(9):1845-1848. PubMed ID: 38949404
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
    Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
    Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
    Gassner FJ; Zaborsky N; Buchumenski I; Levanon EY; Gatterbauer M; Schubert M; Rauscher S; Hebenstreit D; Nadeu F; Campo E; Egle A; Greil R; Geisberger R
    Leukemia; 2021 Apr; 35(4):1053-1063. PubMed ID: 32728184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations driving CLL and their evolution in progression and relapse.
    Landau DA; Tausch E; Taylor-Weiner AN; Stewart C; Reiter JG; Bahlo J; Kluth S; Bozic I; Lawrence M; Böttcher S; Carter SL; Cibulskis K; Mertens D; Sougnez CL; Rosenberg M; Hess JM; Edelmann J; Kless S; Kneba M; Ritgen M; Fink A; Fischer K; Gabriel S; Lander ES; Nowak MA; Döhner H; Hallek M; Neuberg D; Getz G; Stilgenbauer S; Wu CJ
    Nature; 2015 Oct; 526(7574):525-30. PubMed ID: 26466571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.
    Hortal AM; Oeste CL; Cifuentes C; Alcoceba M; Fernández-Pisonero I; Clavaín L; Tercero R; Mendoza P; Domínguez V; García-Flores M; Pintado B; Abia D; García-Macías C; Navarro-Bailón A; Bustelo XR; González M; Alarcón B
    Mol Cancer; 2022 Feb; 21(1):35. PubMed ID: 35120522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.
    Sbarrato T; Horvilleur E; Pöyry T; Hill K; Chaplin LC; Spriggs RV; Stoneley M; Wilson L; Jayne S; Vulliamy T; Beck D; Dokal I; Dyer MJ; Yeomans AM; Packham G; Bushell M; Wagner SD; Willis AE
    Cell Death Dis; 2016 Jun; 7(6):e2249. PubMed ID: 27253413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
    Brieghel C; da Cunha-Bang C; Yde CW; Schmidt AY; Kinalis S; Nadeu F; Andersen MA; Jacobsen LO; Andersen MK; Pedersen LB; Delgado J; Baumann T; Mattsson M; Mansouri L; Rosenquist R; Campo E; Nielsen FC; Niemann CU
    Clin Cancer Res; 2020 Mar; 26(6):1507-1515. PubMed ID: 31919133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ribosomal protein mutations in tumor development (Review).
    Goudarzi KM; Lindström MS
    Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
    Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia (CLL)-Then and now.
    Rai KR; Jain P
    Am J Hematol; 2016 Mar; 91(3):330-40. PubMed ID: 26690614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.